Bristol-Myers Squibb Company, a leading drug manufacturer, is primarily engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products worldwide. The company focuses on a range of therapeutic areas including oncology, cardiovascular, immunology, fibrosis, and others.
Founded in 1887 by William McLaren Bristol and John Ripley Myers, Bristol-Myers Squibb has grown to become a major player in the pharmaceutical industry. It is headquartered in New York, NY, United States.
Bristol-Myers Squibb is known for its wide range of prescription pharmaceuticals in several therapeutic areas, with a notable focus on cancer treatments, cardiovascular drugs, and immunology medications.
|Dr. Giovanni Caforio M.D.||Executive Chairman of the Board||5.76M||N/A||1965|
|Mr. David V. Elkins||Executive VP & CFO||2.72M||2.83M||1968|
|Ms. Sandra Leung Esq.||Executive VP & General Counsel||2.66M||N/A||1961|
|Mr. Greg Meyers||Executive VP and Chief Digital & Technology Officer||N/A||N/A||1973|
|Mr. Timothy Power||VP & Head of Investor Relations||N/A||N/A||N/A|
|Ms. Catherine E. Owen||Senior Vice President of Major Markets||N/A||N/A||1970|
|Mr. John Damonti||President of BMS Foundation||N/A||N/A||N/A|
|Ms. Katherine R. Kelly||VP & Corporate Secretary||N/A||N/A||N/A|
|Mr. Jeffrey Galik||Senior VP & Treasurer||N/A||N/A||N/A|